Product/Composition:- | Glipizide Tablets(IR) |
---|---|
Strength:- | 5 mg, 10 mg |
Form:- | Tablets(IR) |
Reference Brands:- | Glucotrol (US) |
MOQ | As per the manufacturer batch size |
Get Quote Send Enquiry on WhatsApp |
Glipizide stimulates pancreatic β-cells to release insulin by blocking ATP-sensitive potassium channels, enhancing insulin secretion in a glucose-dependent manner. It effectively lowers blood glucose in Type 2 diabetes, especially in patients with residual pancreatic function. Benefits include improved glycemic control, convenient oral dosing, and suitability for early-stage diabetes management.
Glipizide, a sulfonylurea antidiabetic agent, is approved in both the USA (FDA) and EU (EMA) for the treatment of Type 2 Diabetes Mellitus. In the USA, it is marketed under Glucotrol and Glucotrol XL and widely available as generics. In the EU, while not as commonly prescribed due to newer agents, generic Glipizide is authorized in several member states. It is typically used as monotherapy or in combination with other antidiabetics. For wholesale sourcing and global B2B trade, platforms like Pharmatradz.com streamline access to Glipizide formulations from reputed manufacturers and exporters.